期刊文献+

床旁血液净化技术治疗难治性心力衰竭21例分析

下载PDF
导出
摘要 目的观察床旁血液净化技术(CRRT)治疗顽固性心力衰竭的疗效。方法对我院21例经药物治疗疗效不佳的顽固性心力衰竭患者行CRRT治疗。观察患者治疗前后临床症状和体征,血清糖类抗原125(CAl25)、B型尿钠肽(BNP),左室射血分数(LVEF)。结果 21例患者经过1~5d治疗后,8例疗效显著,11例治疗有效,2例治疗无效或者病情恶化及中途退出治疗,总有效率90.4%。CRRT治疗后患者血清CAl25(P<0.05)、血浆BNP(P<0.01)明显低于治疗前,左室射血分数(P<0.05)治疗后明显高于治疗前。结论CRRT治疗顽固性心力衰竭疗效显著。
作者 时俊霞 王芳
出处 《中国医药指南》 2012年第23期258-259,共2页 Guide of China Medicine
  • 相关文献

参考文献8

  • 1Williams AJ,Nicholl JP,Nahas AM,et al.continuous ambulatory peritoneal dialysis and haemodalysis in the elderly[J].Quart J Med,1990,74(274):215.
  • 2Konig Ps,Lhotta K,Kronenberg F,et al.CAPD:a successful treatment in patients suffering from therapy-resistant congestive heart failure[J].Adv Perit Dial,1991,7:97-101.
  • 3Canaud B,LeblancM,Leray Maragues H,et al.Slow continuous and daily ultrafitration for refractory congestive heart failure[J].Nephrol Dial Transplant,1998,13(Suppl 4):51-55.
  • 4沈卫峰.缺血性心力衰竭的研究现况[J].国际心血管病杂志,2006,33(1):1-4. 被引量:10
  • 5MiletoG,Pitrone F,Princi P,et a1.Treatment of refractory heartfailure with diferent dialysis technics[J].Recenti Prog Med,1996,87(2):62-70.
  • 6Ragazzoni E,Sacco A,Cusinato S.et al.Heart failure resistant to drug therapy:Nephrologic approach[J].Minerva Urol Nefrol,1998,50(2):133-138.
  • 7任新生.床旁血液净化在危重病中的应用[J].中华急诊医学杂志,2003,12(2):140-141. 被引量:36
  • 8季大玺,谢红浪,黎磊石.连续性血液净化与非肾脏疾病[J].中国危重病急救医学,2001,13(1):5-9. 被引量:155

二级参考文献24

  • 1[1]Hunt SA,Abraham WT,Chin MH,et al.ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult--summary article[J].Circulation,2005,112(12):1825-1852.
  • 2[2]Khand A,Gemmel I,Clark A,et al.Is the prognosis of heart failure improving?[J].J Am Coll Cardiol,2000,36(7):2284-2286.
  • 3[3]Cleland JG,Swedberg K,Follath F,et al.The Euro Heart Failure survey programme:survey on the quality of care among patients with heart failure in Europe.Part I:patient characteristics and diagnosis[J].Eur Heart J,2003,24(5):442-463.
  • 4[4]He J,Gu D,Wu X,et al.Major causes of death among men and women in China[J].N Engl J Med,2005;353(11):1124-1134.
  • 5[6]Sliwa K,Woodiwiss A,Kone VN,et al.Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline.Results of a randomized study[J].Circulation,2004,109(6):750-755.
  • 6[7]Rizzello V,Poldermans D,Boersma E,et al.Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy.Role of myocardial viability[J].Circulation,2004,110(16):2383-2388.
  • 7[8]Chareonthaitawee P,Gersh B,Araoz PA,et al.Revascularization in severe left ventricular dysfunction.The role of viability testing[J].J Am Coll Cardiol,2005,46(4):567-574.
  • 8[9]Knuuti J,Schelbert HR,Bax JJ.The need for standardization of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischemic left ventricular dysfunction[J].Eur J Nucl Med Imaging,2002,29(9):1257-1266.
  • 9[10]Zoghbi WA.Evaluation of myocardial viability with contrast echocardiography[J].Am J Cardiol,2002,90(10A):65J~71J.
  • 10[11]Wu KC,Lima JA.Noninvasive imaging of myocardial viability:current techniques and future developments[J].Circulation,2003,93(12):1146-1158.

共引文献191

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部